SEC Comment Letter 0000000000-23-011448 to CureVac N.V. (CVAC) (CIK 0001809122)

CureVac N.V. (CVAC) (CIK 0001809122)
Date: Oct. 19, 2023 · CIK: 0001809122 · Accession: 0000000000-23-011448

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 001-39446

Date

October 19, 2023

Author

Pierre Kemula

Form

UPLOAD

Company

CureVac N.V. (CVAC) (CIK 0001809122)

Letter

United States securities and exchange commission logo October 19, 2023 Pierre Kemula Chief Financial Officer CureVac N.V. Friedrich-Miescher-Strasse 15, 72076 Tübingen, Germany Re:CureVac N.V. Form 20-F for the Fiscal Year Ended December 31, 2022 Filed April 25, 2023 File No. 001-39446 Dear Pierre Kemula: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences

Show Raw Text

United States securities and exchange commission logo
October 19, 2023
Pierre Kemula
Chief Financial Officer
CureVac N.V.
Friedrich-Miescher-Strasse 15, 72076
Tübingen, Germany
Re:CureVac N.V.
Form 20-F for the Fiscal Year Ended December 31, 2022
Filed April 25, 2023
File No. 001-39446
Dear Pierre Kemula:
            We have completed our review of your filing. We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences

SecProbe.io